Melinta Therapeutics Inc. buy tamam
Start price
27.03.17
/
50%
€92.46
Target price
27.09.17
€225.50
Performance (%)
-25.61%
End price
27.09.17
€68.78
Summary
This prediction ended on 27.09.17 with a price of €68.78. The price of Melinta Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.61%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by tamam for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
Cempra, either Merck or Pfizer is interested in buying it
Bullish macht mich auch der Chartverlauf:
The daily price of CEMP shows a steadily rising trend off the late December lows on strong share accumulation. 4.75 is near-term resistance -- the high set by the Phase III endpoint news by Fusidic Acid -- and shares are now holding steady at 4.10.
(Laufzeit überschritten)
Stopped prediction by tamam for Melinta Therapeutics Inc.
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€426.53
21.01.16
21.01.16
€676.50
21.07.16
21.07.16
-5.05%
21.07.16
21.07.16
